SURGE Therapeutics

Seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed.

HQ location

Cambridge, United States

Website

Launch date

2016

Employees

Enterprise value

$128—192m

https://x.com/surge_tx_https://www.linkedin.com/company/surge-therapeutics/

biotechnology

Get premium to view all results

Date	Investors	Amount	Round
-	investor investor	€0.0	round
Sep 2019	investor	€0.0	round
Nov 2020	investor	€0.0	round
Oct 2022	investor investor investor investor investor investor investor	€0.0	round
Jul 2023*	Pitango Venture Capital Khosla Ventures 8VC KdT Ventures Piedmont Capital Alumni Ventures Cancer Research Institute Intuitive VC Camford Capital Bioluminescence Ventures	$32.0m	Series B
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads